Clinical Trial: A Study of HW243040 in Healthy Participants

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737496) titled 'A Study of HW243040 in Healthy Participants' on July 27.

Brief Summary: This is a randomised, double-blind, placebo-controlled clinical trial intended to evaluate the safety, tolerability and pharmacokinetic profiles of HW243040 following single and multiple administrations in healthy study participants.

Study Start Date: Aug. 10

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: HW243040

HW243040 will be administered orally under fasting or fed conditions.

DRUG: Placebo

Placebo will be administered orally under fasting or fed conditions.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hubei Bio-Pharmaceuti...